Our results are consistent with these published data, showing that the blockage of Nogo/NgR pathway significantly attenuated amyloidogenic processing of APP and the activity of GSK3β in AD mice, which reduced Aβ deposition and phosphorylated levels of tau, respectively. This evidence concerns the gene RTN4 and Alzheimer disease.